zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - medicin for obstruktiv sygdomme, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
glyronul 0,2 mg/ml injektionsvæske, opløsning
eql pharma ab - glycopyrroniumbromid - injektionsvæske, opløsning - 0,2 mg/ml
robinul-neostigmin 0,5 + 2,5 mg/ml injektionsvæske, opløsning
viatris aps - glycopyrroniumbromid, neostigminmethylsulfat - injektionsvæske, opløsning - 0,5 + 2,5 mg/ml
axhidrox 2,2 mg/dosis creme
dr. august wolff gmbh & co. kg arzneimittel - glycopyrroniumbromid - creme - 2,2 mg/dosis
copneg 0,5+2,5 mg/ml injektionsvæske, opløsning
eql pharma ab - glycopyrroniumbromid, neostigminmethylsulfat - injektionsvæske, opløsning - 0,5+2,5 mg/ml
robinul 0,2 mg/ml injektionsvæske, opløsning
viatris aps - glycopyrroniumbromid - injektionsvæske, opløsning - 0,2 mg/ml
robinul 0,2 mg/ml injektionsvæske, opløsning
orifarm a/s - glycopyrroniumbromid - injektionsvæske, opløsning - 0,2 mg/ml
robinul 0,2 mg/ml injektionsvæske, opløsning
paranova danmark a/s - glycopyrroniumbromid - injektionsvæske, opløsning - 0,2 mg/ml
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.